Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Lemzoparlimab
Trade Name
Synonyms TJC4|TJ 011133|TJ-011133|TJ011133
Drug Descriptions

Lemzoparlimab (TJ011133) is a monocloncal antibody targeting CD47, which blocks the interaction of CD47 with SIRPA to enhance macrophage mediated phagocytosis of tumor cells (Blood (2019) 134 (Supplement_1): 4063).

DrugClasses CD74 Antibody 3
CAS Registry Number 2377483-71-9
NCIT ID C163977

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Azacitidine + Lemzoparlimab Azacitidine Lemzoparlimab 0 1
Azacitidine + Lemzoparlimab + Venetoclax Azacitidine Lemzoparlimab Venetoclax 0 1
Carfilzomib + Dexamethasone + Lemzoparlimab Carfilzomib Dexamethasone Lemzoparlimab 0 1
Daratumumab + Dexamethasone + Lemzoparlimab Daratumumab Dexamethasone Lemzoparlimab 0 1
Dexamethasone + Lemzoparlimab Dexamethasone Lemzoparlimab 0 1
Dexamethasone + Lemzoparlimab + Pomalidomide Dexamethasone Lemzoparlimab Pomalidomide 0 1
Lemzoparlimab Lemzoparlimab 0 2
Lemzoparlimab + Pembrolizumab Lemzoparlimab Pembrolizumab 0 1
Lemzoparlimab + Rituximab Lemzoparlimab Rituximab 0 1
Lemzoparlimab + Venetoclax Lemzoparlimab Venetoclax 0 0


Additional content available in CKB BOOST